共 23 条
[1]
NICE Guide to the Methods of Technology Appraisal, (2004)
[2]
Guidelines for the Pharmaceutical Industry on the Submission to the Pharmaceutical Benefits Advisory Committee, (1992)
[3]
Ontario Guidelines for the Economic Evaluation of Pharmaceutical Products, (1994)
[4]
Brazier J., Deverill M., Green C., Harper R., Booth A., A review of the use of health status measures in economic evaluation, Health Technol. Assess., 3, 1-4, pp. 1-164, (1999)
[5]
Tosteson A.N.A., Gabriel S.E., Kneeland T.S., Moncur M.M., Manganiello P.D., Schiff I., Ettinger B., Melton L.J., Has the impact of hormone replacement therapy on health-related quality of life been undervalued?, J. Womens Health Gend Based Med., 9, pp. 110-130, (2000)
[6]
Zoellner Y.F., Oliver P., Brazier J.E., Alt J., Schaefer M., Reliability and validity of a newly developed menopause-specific quality-of-life questionnaire, the QualiPause Inventory (QPI), Qual. Life Res., 10, (2001)
[7]
Brazier J.E., Kolotkin R.L., Crosby R.D., Williams G.R., Estimating a preference-based index from the Impact of Weight on Quality of Life Instrument (IWQOL-Lite) from the SF-6D, Value Health, 7, pp. 490-498, (2004)
[8]
Tsuchyia A., Brazier J., McColl E., Parkin D., Deriving preference-based condition-specific instruments: Converting AQLQ into EQ-5D indices, (2002)
[9]
Dixon S., McEwan P., Currie C.J., Estimating the health utility of treatment in adults with growth hormone deficiency, J. Outcomes Res., 7, pp. 1-12, (2003)
[10]
Brazier J.E., Dixon S., Condition specific measures in economic appraisal, Health Econ., 4, pp. 255-264, (1995)